Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Madrenas

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|March 27, 2001
Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3L A Chau, J Y Tso, J Madrenas
Microsurgery|April 3, 1999
Surgical technique for vascularized thymus transplantation in miceJ Jiang, H Wang, J Madrenas, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1993
Ly-6 in kidney is widely expressed on tubular epithelium and vascular endothelium and is up-regulated by interferon gammaP G Blake, J Madrenas, P F Halloran
Kidney International|February 1, 1991
Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritisJ Madrenas, N A Parfrey, P F Halloran
Transplantation Proceedings|February 1, 1989
The mediators of inflammation (interleukin 1, interferon-tau, and tumor necrosis factor) and their relevance to rejectionP F Halloran, S M Cockfield, J Madrenas
The Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J Madrenas
Proceedings of the National Academy of Sciences of the United States of America|September 3, 1996
Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonistsJ Madrenas, R H Schwartz, R N Germain
Immunological Investigations|December 1, 1992
Complement-dependent cytotoxicity for negative selection at the mRNA levelN S Gill, J Madrenas, P F Halloran
Medicina Clinica|March 24, 1984
[Polymyositis and lung carcinoma]J Madrenas Puig, L Padró Ubeda, A Codina Puiggrós
Autoimmunity|August 25, 2000
Prevention of diabetes mellitus in the non-obese diabetic mouse strain with monoclonal antibodies against the CD45RB moleculeM M Abu-Hadid, A I Lazarovits, J Madrenas
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|March 27, 2001
Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3L A Chau, J Y Tso, J Madrenas
Microsurgery|April 3, 1999
Surgical technique for vascularized thymus transplantation in miceJ Jiang, H Wang, J Madrenas, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1993
Ly-6 in kidney is widely expressed on tubular epithelium and vascular endothelium and is up-regulated by interferon gammaP G Blake, J Madrenas, P F Halloran
Kidney International|February 1, 1991
Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritisJ Madrenas, N A Parfrey, P F Halloran
Transplantation Proceedings|February 1, 1989
The mediators of inflammation (interleukin 1, interferon-tau, and tumor necrosis factor) and their relevance to rejectionP F Halloran, S M Cockfield, J Madrenas
The Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J Madrenas
Proceedings of the National Academy of Sciences of the United States of America|September 3, 1996
Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonistsJ Madrenas, R H Schwartz, R N Germain
Immunological Investigations|December 1, 1992
Complement-dependent cytotoxicity for negative selection at the mRNA levelN S Gill, J Madrenas, P F Halloran
Medicina Clinica|March 24, 1984
[Polymyositis and lung carcinoma]J Madrenas Puig, L Padró Ubeda, A Codina Puiggrós
Autoimmunity|August 25, 2000
Prevention of diabetes mellitus in the non-obese diabetic mouse strain with monoclonal antibodies against the CD45RB moleculeM M Abu-Hadid, A I Lazarovits, J Madrenas
Pageof 7